Gene Query: DOK7

Dataset Description Geneva Score
Silencing p300 in MCF7 cells to study expression and alternative splicing 53.55
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 49.24
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 49.24
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 41.08
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 41.08
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 30.34
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 30.34
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 29.49
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 29.49
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 22.58
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 22.58
Transcriptome analysis in Neobractatin treated cells 17.75
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 17.41
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 16.02
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 14.26
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 12.82
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 12.82
RNAseq of cell lines with knocked in ESR1 mutations 12.71
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 11.79
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 10.71
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 10.41
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 9.84
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 9.61
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 9.33
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 9.17
NR2F2 study 9.02
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 9.02
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 8.65
Epigenomic landscape during organ formation in human early embryos 8.6
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 8.54
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 8.54
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 8.39
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 8.37
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 8.35
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 8.35
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 8.0
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 8.0
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 7.38
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 7.38
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 7.29
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 7.21
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 7.06
BASP1 modifies the Tamoxifen response 7.01
RNA-Seq analysis of breast cancer cells after shikonin treatment 6.83
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 6.81
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 6.51
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 6.45
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 6.21
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 6.21
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 5.77
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 5.75
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 5.73
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 5.58
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 5.54
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 5.37
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 5.22
Differential Protein Occupancy Profiling of the mRNA Transcriptome 5.16
CUREfast: Accelerating research with families 5.06
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 4.66
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 4.44
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 4.36
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 4.36
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 4.29
RNA sequencing of GlyH-101-treated MCF-7 cell line 4.25
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 4.24
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 4.24
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 4.18
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 4.18
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 4.13
Comparing gene expression in iPSC derived RPE from control and AMD donors 3.98
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 3.97
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 3.97
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 3.94
3.78
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 3.76
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 3.76
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.7
Conservative alteration of chromosomal expression pattern across human solid tumor types 3.68
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 3.66
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 3.66
BAF controls genome accessibility 3.62
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 3.6
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 3.57
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 3.4
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 3.35
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 3.08
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 3.07
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 2.99
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 2.99
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 2.95
Ebola virus (EBOV) infection of ARPE-19 cells 2.86
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 2.74
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.65
snRNAs as regulators of alternative splicing 2.41
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 2.39
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 2.37
Expression charcaterization of an internal protocol developed to differentiate RPE cells 2.37
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 2.34
Gene expression profiling of human and murine in vitro muscle differentiation 2.33
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 2.2
PTHrP overexpression in MCF7 cells 2.13
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 2.08
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 2.08
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.07
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.07
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 2.04
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 2.02
Gene expression profiling of papillary thyroid cancer from central and invasive regions 2.01
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 1.94
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 1.94
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 1.92
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 1.91
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 1.89
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 1.87
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 1.87
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 1.83
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 1.83
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 1.79
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 1.79
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 1.77
RNA-seq analysis and shRNA screen of breast cancer 1.76
RNA-seq analysis of breast cancer 1.76
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 1.73
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 1.73
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.72
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 1.7
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 1.68
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 1.67
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 1.66
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 1.65
Illumina HiSeq Sequencing on Breast cancer PDX samples 1.64
Overexpression of NFIB and YBX1 in MCF-7 cells 1.64
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 1.62
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 1.59
Expression profiling of MCF-7 cells with treatment of TCDD 1.56
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 1.56
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.54
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 1.5
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 1.49
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.48
Capturing the Interactome of Newly Transcribed RNA 1.48
Capturing the Interactome of Newly Transcribed RNA (RICK) 1.48
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.44
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.44
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.44
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 1.44
Interaction between mitoNEET and NAF-1 in cancer cells 1.43
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 1.42
Gene expression profile in breast cancer cell lines using RNA sequencing 1.41
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 1.35
Gene Expression Profiling of WT and KDM3A Knocked out Cell 1.34
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 1.34
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 1.34
Gene expression analysis of breast cancer cell-lines 1.33
Gene expression and genome-wide location analysis of breast cancer cell-lines 1.33
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.31
EWSR1 influences alternative splicing through direct and indirect mechanisms 1.3
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 1.29
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.29
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 1.28
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 1.27
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 1.25
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 1.25
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 1.24
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 1.24
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 1.22
Patient-derived luminal breast cancer xenografts with progestins 1.19
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 1.19
Genome wide expression change in LCC2 and MCF-7 cells 1.18
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 1.17
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 1.17
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 1.16
Active translatome profiling with RiboLace in MCF7 cells 1.16
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.15
RNAseq of Breast cancer PDX samples 1.13
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 1.13
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.11
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 1.1
BET bromodomain inhibition 1.1
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 1.1
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 1.08
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 1.08
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 1.07
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 1.07
UV_24h_GRO-Seq 1.07
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 1.06
Interphase condensins regulate ligand-depedent enhancer activation 1.05
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 1.05
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 1.05
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 1.04
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.04
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 1.02
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 1.01
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 0.99
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 0.99
Differential Gene Expression between MCF10A and MCF7 cells 0.95
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 0.94
Repurposing of promoters and enhancers during mammalian evolution 0.94
BACH2 in human plasma cell fate decision 0.92
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.91
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.91
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.9
RNA sequencing of human pancreatic cancer cell lines 0.9
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 0.9
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.9
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.89
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.88
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.88
Preclinical model of obesity and ER-positive breast cancer 0.87
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.85
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 0.85
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.82
Bone marrow derived human B cells [normal proB] 0.82
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.82
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 0.81
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 0.81
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 0.8
RNA-Seq of PRMT1 overexpression ECA109 cells 0.79
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  0.79
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 0.78
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 0.78
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 0.76
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 0.75
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 0.74
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 0.72
Energy Metabolism during Anchorage-Independence 0.71
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 0.71
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.69
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 0.69
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 0.69
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 0.69
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 0.68
MCF-7 as a model for functional analysis of breast cancer risk variants 0.68
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 0.66
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 0.66
Genome wide expression change by RNF168 knocking down in MCF-7 cells 0.66
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 0.65
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.65
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.65
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 0.64
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 0.64
RNA-seq analyisis of PUM2 knockout cells 0.62
Disruption of the exocyst induces podocyte loss and dysfunction 0.62
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 0.62
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.62
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.62
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.62
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 0.61
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 0.61
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 0.61
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 0.6
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.59
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 0.59
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 0.59
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.59
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 0.58
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 0.58
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 0.58
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 0.58
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.55
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 0.55
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 0.55
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 0.55
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 0.55
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.54
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 0.54
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 0.54
Primary Human B-cell Temporal Response to CD40L Stimulation 0.53
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.53
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.52
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 0.52
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 0.52
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 0.51
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.51
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 0.51
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 0.5
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.49
Transcriptional profiles of normal human mature B cells 0.49
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 0.49
Fusion discovery in breast cancer cell line 0.49
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 0.49
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 0.48
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 0.47
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 0.47
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 0.47
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 0.46
Recovery and analysis of nascent RNA 0.46
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.46
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 0.46
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 0.46
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 0.46
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 0.45
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.44
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 0.44
Toxoplasma gondii infection of human retinal pigment epithelial cells 0.44
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 0.44
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 0.44
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 0.44
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 0.43
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 0.42
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 0.42
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 0.42
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 0.41
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 0.41
RNA-seq of YB5 cells treated with Proscillaridin A 0.41
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 0.4
Transcriptional profiling of LS1034 cells treated with tepoxalin 0.4
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.4
RNA-seq differential expression studies: more sequence, or more replication? 0.38
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.37
MCF10A H-Ras RNA-Seq 0.37
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 0.37
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 0.37
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 0.36
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.36
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 0.36
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 0.36
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 0.36
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.36
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 0.36
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 0.36
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 0.36
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 0.36
Dynamic reorganization of nuclear architecture during human cardiogenesis 0.36
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 0.36
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 0.36
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.36
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.35
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.35
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.35
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 0.35
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 0.35
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 0.35
Endometrial transcriptome and PGR cistrome in cycling fertile women 0.35
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 0.35
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 0.34
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.34
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.34
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 0.34
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 0.34
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 0.33
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 0.33
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.31
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.31
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 0.31
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.31
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 0.3
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.3
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.3
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 0.3
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.29
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 0.29
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 0.29
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 0.29
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.28
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.28
Transcriptome of human white and brown adipose tissue biopsies 0.28
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 0.28
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.28
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.28
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 0.27
Gene expression of thyroid cancer cell lines 0.27
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.27
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 0.26
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.26
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 0.26
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.26
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 0.25
A practical evaluation of alignment algorithms for RNA variant calling analysis 0.25
Effect of ILF3 on translation during homeostasis and the antiviral response 0.25
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 0.24
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.24
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.24
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 0.23
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.23
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.23
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.23
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 0.22
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 0.22
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 0.22
Rorc disruption in human FG pancreatic cancer cells 0.21
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 0.21
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.21
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 0.21
Dilated cardiomyopathy vs Myocarditis 0.21
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 0.21
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.21
The role of the Calcium-Sensing receptor in colorectal cancer 0.21
RNA splicing alteration on glioblastoma and normal neural stem cells 0.21
circRNA profile in hypopharyngeal cancer 0.21
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.21
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.2
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 0.2
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.2
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.2
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.2
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.2
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 0.2
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.19
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.19
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.19
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.18
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 0.18
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 0.18
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 0.18
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.18
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.17
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.17
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.17
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.17
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.17
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.17
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.16
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.16
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.16
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.16
Regulation of poly(A) tail and translation during the somatic cell cycle 0.15
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.15
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.15
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.15
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 0.14
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.14
HEK293 Heat-shock experiment 0.14
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 0.14
Selective expression of long non-coding RNAs in a breast cancer cell progression model 0.14
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.13
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.13
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.13
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 0.13
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 0.13
Transposon-based construction of strand-specific RNA-seq libraries 0.13
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.13
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 0.12
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 0.12
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.12
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.12
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 0.11
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 0.11
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.11
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 0.11
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.11
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 0.1
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.1
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.1
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.1
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.1
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.1
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.1
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 0.1
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.1
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 0.09
H1609088 Human RNA-Sequencing 0.09
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 0.09
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 0.09
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 0.09
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.09
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.09
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.08
CSL RNA-Seq on HKC and SCC cell lines 0.08
CSL 0.08
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.08
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.08
mRNA-sequencing of breast cancer subtypes and normal tissue 0.08
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 0.08
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.07
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 0.07
Molecular analysis of renal cell carcinoma with unclassfied histology 0.06
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.06
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.06
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 0.06
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 0.05
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 0.05
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 0.05
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.05
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.05
RNA-seq in endometrial stromal tumors 0.05
RNA-sequencing of healthy human skeletal myocytes 0.05
Characterization of human ILC2 subsets 0.04
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.04
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.04
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.04
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.04
Modeling Human Cancer-induced Cachexia (Human) 0.04
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 0.03
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.03
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.03
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.02
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.02
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.02
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 0.01
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.01
Enhancer activation during EGF response 0.01
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.01
The circadian transcriptional landscape in primary human mammary epithelial cells 0.01
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 0.01
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 0.0
Loss of endometrial plasticity in recurrent pregnancy loss 0.0
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.0
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.0
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation